# The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)

> **NCT05820048** · PHASE4 · UNKNOWN · sponsor: **Daejeon St. Mary's hospital** · enrollment: 300 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Lansoprazole 15 mg

## Key facts

- **NCT ID:** NCT05820048
- **Lead sponsor:** Daejeon St. Mary's hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2025-07-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05820048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05820048, "The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05820048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*